2013
DOI: 10.3389/fimmu.2013.00499
|View full text |Cite
|
Sign up to set email alerts
|

Signatures of Human NK Cell Development and Terminal Differentiation

Abstract: Natural killer (NK) cells are part of the innate lymphoid cell (ILC) family and represent the main cytotoxic population. NK cells develop from bone marrow common lymphoid progenitors and undergo terminal differentiation in the periphery, where they finally gain their cytotoxic competence as well as the ability to produce IFN-γ in response to engagement of activating receptors. This process has been at least partially elucidated and several markers have been identified to discriminate different NK cell stages a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
106
0

Year Published

2014
2014
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 121 publications
(110 citation statements)
references
References 61 publications
4
106
0
Order By: Relevance
“…That DCs and NK cells are not confined to the lungs in aSS patients suggests that NK cell-DC cross-talk could be at play in secondary lymphoid organs, rather than in target tissues. However, the significant phenotypic and functional changes of blood NK cells reported in the present study are consistent with the modulation of NK cell differentiation, previously described in humans (19,(30)(31)(32): NK cells from active aSS patients displayed a differentiated phenotype with low levels of NKp30, associated with high expressions of CD57 and ILT2. These results are further supported by the accuracy of the equation combining these three variables in predicting the activity of aSS.…”
Section: Discussionsupporting
confidence: 92%
“…That DCs and NK cells are not confined to the lungs in aSS patients suggests that NK cell-DC cross-talk could be at play in secondary lymphoid organs, rather than in target tissues. However, the significant phenotypic and functional changes of blood NK cells reported in the present study are consistent with the modulation of NK cell differentiation, previously described in humans (19,(30)(31)(32): NK cells from active aSS patients displayed a differentiated phenotype with low levels of NKp30, associated with high expressions of CD57 and ILT2. These results are further supported by the accuracy of the equation combining these three variables in predicting the activity of aSS.…”
Section: Discussionsupporting
confidence: 92%
“…37 Moreover, NK cells differentiate through the life course, reflecting the interplay of genes and environment. These adaptations substantially modify NK cell function 20,38,39 and are beginning to be associated with health outcomes. 9 Age is a major determinant of NK cell phenotype and function, 18-22 but it is not yet clear whether this is a result of primary, age-intrinsic processes or whether age is simply a marker for cumulative environmental exposures.…”
Section: Discussionmentioning
confidence: 99%
“…Although these cells are considered components of the innate immunity, some specific types of NK cells have been shown to proliferate in response to certain viral infections, including infection with HCMV. 9,10 Several markers that could be used to better characterize the different phases of NK cell maturation are being studied. Based on the expression of CD56, two subsets of these cells have been identified: CD56bright and CD56dim.…”
Section: 4mentioning
confidence: 99%
“…Within this context, some studies claim that CD57 -CD56bright NK cells are precursors of CD57 + CD56dim cells. 9,10 Thus, CD57 is a very useful marker of NK cell maturation and activation and has been used in experiments to consistently detect these cells.…”
Section: 4mentioning
confidence: 99%